Reid Alexander Waldman
Chief Executive Officer at Veradermics Incorporated
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 1 year
- Director since
- 2026
1 year of board service in total across 2 boards, counting each seat separately. Longest: Veradermics Incorporated, 7 months.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Achieve Life Sciences Inc. July 2, 202699.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Veradermics Incorporated | Option exercise | +3,452 | $12.19 | $42,080 |
| Aug 17, 2026 | Veradermics Incorporated | Open-market sale | −11,527 | $106.72 | $1,230,161 |
| Aug 17, 2026 | Veradermics Incorporated | Open-market sale | −25,234 | $107.53 | $2,713,412 |
| Aug 17, 2026 | Veradermics Incorporated | Open-market sale | −27,490 | $108.45 | $2,981,291 |
| Aug 17, 2026 | Veradermics Incorporated | Open-market sale | −3,000 | $109.38 | $328,140 |
| Aug 17, 2026 | Veradermics Incorporated | Open-market sale | −249 | $111.28 | $27,709 |
| Feb 5, 2026 | Veradermics Incorporated | Derivative conversion | +1,437 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.